ICAM1 and neoplasm: Pretreatment with CD54 antibody decreased the tumor accumulation of DOX@E-PSiNPs, suggesting that similar to the cross-reactive cellular uptake by cancer cells, CD54 was also involved in the enhanced tumor accumulation of DOX@E-PSiNPs (Supplementary Fig. 22).